[1] SAMANIEGO E A，GIBSON E，NAKAGAWA D，

et al. Safety of tirofiban and dual antiplatelet therapy

in treating intracranial aneurysms[J]. Stroke Vasc

Neuro，2019，4（1）：36-42.

[2] HAHNEMANN M L，RINGELSTEIN A，

SANDALCIOGLU I E，et al. Silent embolism

after stent-assisted coiling of cerebral aneurysms：

diffusion-weighted MRI study of 75 cases[J].

Neurointerv Surg，2014，6（6）：461-465.

[3] ZAKERI A S，NIMJEE S M. Use of Antiplatelet

agents in the neurosurgical patient[J]. Neurosurg

Clin N Am，2018，29（4）：517-527.

[4] DORNBOS D 3rd，KATZ J S，YOUSSEF P，et al.

Glycoprotein Ⅱb/Ⅲa inhibitors in prevention and

rescue treatment of thromboembolic complications

during endovascular embolization of intracranial

aneurysms[J]. Neurosurgery，2018，82（3）：268-277.

[5] Effects of platelet glycoprotein Ⅱb/Ⅲa blockade

with tirofiban on adverse cardiac events in

patients with unstable angina or acute myocardial

infarction undergoing coronary angioplasty. The

RESTORE Investigators. Randomized Efficacy

Study of Tirofiban for Outcomes and Restenosis[J].

Circulation，1997，96（5）：1445-1453.

[6] STEINHUBL S R，TALLEY J D，BRADEN G

A，et al. Point-of-care measured platelet inhibition

correlates with a reduced risk of an adverse cardiac

event after percutaneous coronary intervention：

results of the GOLD（AU-Assessing Ultegra）

multicenter study[J]. Circulation，2001，103（21）：

2572-2578.

[7] LEVITT M R，MOON K，ALBUQUERQUE F

C，et al. Intraprocedural abciximab bolus versus

pretreatment oral dual antiplatelet medication for

endovascular stenting of unruptured intracranial

aneurysms[J]. J Neurointerv Surg，2016，8（9）：

909-912.

[8] YI H J，GUPTA R，JOVIN T G，et al. Initial

experience with the use of intravenous eptifibatide

bolus during endovascular treatment of intracranial

aneurysms[J]. AJNR Am J Neuroradiol，2006，27

（9）：1856-1860.

[9] SEDAT J，CHAU Y，GAUDARD J，et al.

Administration of eptifibatide during endovascular

treatment of ruptured cerebral aneurysms reduces

the rate of thromboembolic events[J]. Neuroradiology，

2015，57（2）：197-203.

[10] LIANG X D，WANG Z L，LI T X，et al. Safety and

efficacy of a new prophylactic tirofiban protocol

without oral intraoperative antiplatelet therapy for

endovascular treatment of ruptured intracranial

aneurysms[J]. J Neurointerv Surg，2016，8（11）：

1148-1153.

[11] KIM S，CHOI JH，KANG M，et al. Safety and

efficacy of intravenous tirofiban as antiplatelet

premedication for stent-assisted coiling in acutely

ruptured intracranial aneurysms[J]. AJNR Am J

Neuroradiol，2016，37（3）：508-514.